Primary study · included by 2 reviews

Saliva changes in Parkinson’s disease patients after injection of Botulinum neurotoxin type A

Tiigimae-Saar 2018 · Tiigimäe-Saar Janne, Tamme Tiia, Rosenthal Marika, et al. · Neurological Sciences · 2018

doi:10.1007/s10072-018-3279-4journal-article

Trial PICO

Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.

Results

Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.

Included by

Oral health effects of botulinum toxin treatment for drooling: a systematic review.

Non-Cochrane · intervention · 2021 · cited as Tiigimae-Saar 2018 · References [22]; Results (buffering capacity; oral pH; S. mutans; Lactobacilli); Table 1 (quasi-experimental)

The review does not say which of its outcomes this study informs.

The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis.

Non-Cochrane · intervention · 2023 · cited as Tiigimae-Saar 2018 · Table 1 (labeled 'Janne' [47]); Ref [47] (Neurol Sci 2018); adverse events only (Fig. 6, BoNt-A); did not report DSFS

The review does not say which of its outcomes this study informs.

2 including reviews in total.